249 related articles for article (PubMed ID: 21652078)
21. Intravesical mitomycin C combined with hyperthermia for patients with T1G3 transitional cell carcinoma of the bladder.
Halachmi S; Moskovitz B; Maffezzini M; Conti G; Verweij F; Kedar D; Sandri SD; Nativ O; Colombo R
Urol Oncol; 2011; 29(3):259-64. PubMed ID: 19395285
[TBL] [Abstract][Full Text] [Related]
22. [The topical application of mitomycin C in the treatment of scar formation and stenosis in hollow organs of the head and neck: a field report].
Bast F; Risteska K; Jovanovic S; Sedlmaier B
Laryngorhinootologie; 2009 Aug; 88(8):528-33. PubMed ID: 19554503
[TBL] [Abstract][Full Text] [Related]
23. Successful treatment of recurrent corneal intraepithelial neoplasia with topical mitomycin C.
Tseng SH; Tsai YY; Chen FK
Cornea; 1997 Sep; 16(5):595-7. PubMed ID: 9294697
[TBL] [Abstract][Full Text] [Related]
24. Topical mitomycin-C for pterygia: is single application appropriate?
Rubinfeld RS; Stein RM
Ophthalmic Surg Lasers; 1997 Aug; 28(8):662-9. PubMed ID: 9268998
[TBL] [Abstract][Full Text] [Related]
25. Conjunctival melanoma: the role of conservative surgery and radiotherapy in regional metastatic disease.
Tatla T; Hungerford J; Plowman N; Ghufoor K; Keene M
Laryngoscope; 2005 May; 115(5):817-22. PubMed ID: 15867646
[TBL] [Abstract][Full Text] [Related]
26. Topical mitomycin C chemotherapy for conjunctival melanoma and PAM with atypia.
Finger PT; Czechonska G; Liarikos S
Br J Ophthalmol; 1998 May; 82(5):476-9. PubMed ID: 9713051
[TBL] [Abstract][Full Text] [Related]
27. Long-term outcomes after adjunctive topical 5-flurouracil or mitomycin C for the treatment of surgically excised, localized ocular surface squamous neoplasia.
Bahrami B; Greenwell T; Muecke JS
Clin Exp Ophthalmol; 2014; 42(4):317-22. PubMed ID: 23927413
[TBL] [Abstract][Full Text] [Related]
28. Long-term outcomes of intraoperative 5-fluorouracil versus intraoperative mitomycin C in primary trabeculectomy surgery.
Palanca-Capistrano AM; Hall J; Cantor LB; Morgan L; Hoop J; WuDunn D
Ophthalmology; 2009 Feb; 116(2):185-90. PubMed ID: 18930550
[TBL] [Abstract][Full Text] [Related]
29. Topical cyclosporine-a combined with mitomycin C for conjunctival and corneal squamous cell carcinoma.
Tunc M; Erbilen E
Am J Ophthalmol; 2006 Oct; 142(4):673-5. PubMed ID: 17011863
[TBL] [Abstract][Full Text] [Related]
30. Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b.
Boehm MD; Huang AJ
Ophthalmology; 2004 Sep; 111(9):1755-61. PubMed ID: 15350333
[TBL] [Abstract][Full Text] [Related]
31. Periocular allergic contact dermatitis following topical Mitomycin C eye drop application.
Cumurcu T; Sener S; Cavdar M
Cutan Ocul Toxicol; 2011 Sep; 30(3):239-40. PubMed ID: 21309691
[TBL] [Abstract][Full Text] [Related]
32. Risk factors for ocular surface squamous neoplasia recurrence after treatment with topical mitomycin C and interferon alpha-2b.
Besley J; Pappalardo J; Lee GA; Hirst LW; Vincent SJ
Am J Ophthalmol; 2014 Feb; 157(2):287-293.e2. PubMed ID: 24184223
[TBL] [Abstract][Full Text] [Related]
33. Results of intraoperative 5-fluorouracil or lower dose mitomycin-C administration on initial trabeculectomy surgery.
Smith MF; Doyle JW; Nguyen QH; Sherwood MB
J Glaucoma; 1997 Apr; 6(2):104-10. PubMed ID: 9098818
[TBL] [Abstract][Full Text] [Related]
34. Conjunctival autografting combined with low-dose mitomycin C for prevention of primary pterygium recurrence.
Frucht-Pery J; Raiskup F; Ilsar M; Landau D; Orucov F; Solomon A
Am J Ophthalmol; 2006 Jun; 141(6):1044-1050. PubMed ID: 16546105
[TBL] [Abstract][Full Text] [Related]
35. Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia: a multicenter experience.
Frucht-Pery J; Sugar J; Baum J; Sutphin JE; Pe'er J; Savir H; Holland EJ; Meisler DM; Foster JA; Folberg R; Rozenman Y
Ophthalmology; 1997 Dec; 104(12):2085-93. PubMed ID: 9400769
[TBL] [Abstract][Full Text] [Related]
36. Protection of the conjunctival flap from contact with mitomycin C during tunnel-trabeculectomy.
Ophir A; Karatas M
Eye (Lond); 2007 Nov; 21(11):1395-402. PubMed ID: 16751753
[TBL] [Abstract][Full Text] [Related]
37. Mitomycin C and the endoscopic treatment of laryngotracheal stenosis: are two applications better than one?
Smith ME; Elstad M
Laryngoscope; 2009 Feb; 119(2):272-83. PubMed ID: 19160408
[TBL] [Abstract][Full Text] [Related]
38. Topical mitomycin-C for treatment of partially-excised ocular surface squamous neoplasia.
Rahimi F; Alipour F; Ghazizadeh Hashemi H; Hashemian MN; Mehrdad R
Arch Iran Med; 2009 Jan; 12(1):55-9. PubMed ID: 19111031
[TBL] [Abstract][Full Text] [Related]
39. Intraoperative mitomycin-C versus postoperative topical mitomycin-C drops for the treatment of pterygium.
Helal M; Messiha N; Amayem A; el-Maghraby A; Elsherif Z; Dabees M
Ophthalmic Surg Lasers; 1996 Aug; 27(8):674-8. PubMed ID: 8858633
[TBL] [Abstract][Full Text] [Related]
40. Intumescent cataract after topical mitomycin-C for conjunctival malignant melanoma.
Sacu S; Ségur-Eltz N; Horvat R; Lukas JR; Zehetmayer M
Am J Ophthalmol; 2003 Aug; 136(2):375-7. PubMed ID: 12888073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
